Senti Biosciences (SNTI) Short Interest Ratio & Short Volume $2.33 +0.08 (+3.56%) (As of 05:20 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Senti Biosciences Short Interest DataSenti Biosciences (SNTI) has a short interest of 65,100 shares, representing 2.27% of the float (the number of shares available for trading by the public). This marks a 9.97% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 227,044 shares to cover all short positions.Current Short Interest65,100 sharesPrevious Short Interest59,200 sharesChange Vs. Previous Month+9.97%Dollar Volume Sold Short$141,267.00Short Interest Ratio2.5 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares4,580,000 sharesFloat Size2,870,000 sharesShort Percent of Float2.27%Today's Trading Volume3,011 sharesAverage Trading Volume227,044 sharesToday's Volume Vs. Average1% Short Selling Senti Biosciences? Sign up to receive the latest short interest report for Senti Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNTI Short Interest Over TimeSNTI Days to Cover Over TimeSNTI Percentage of Float Shorted Over Time Ad Porter & CompanyElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. Senti Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202465,100 shares $141,267.00 +10.0%2.3%2.5 $2.17 10/15/202459,200 shares $120,477.92 -14.7%2.1%1.4 $2.04 9/30/202469,400 shares $156,844.00 -0.7%2.4%1.4 $2.26 9/15/202469,900 shares $214,593.00 -9.5%2.4%0.1 $3.07 8/31/202477,200 shares $204,580.00 -30.9%2.7%0.1 $2.65 8/15/2024111,700 shares $255,793.00 +86.2%4.0%0.2 $2.29 Get the Latest News and Ratings for SNTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. 7/31/202460,000 shares $138,600.00 +38.9%2.2%0.1 $2.31 7/15/202443,200 shares $136,036.80 -70.6%1.6%0.1 $3.15 6/30/20241,470,000 shares $405,720.00 +443.0%5.3%0.2 $0.28 6/15/2024270,700 shares $66,700.48 +8.5%1.0%0.3 $0.25 5/31/2024249,500 shares $74,850.00 -11.3%0.9%2 $0.30 5/15/2024281,400 shares $106,366.39 -2.1%1.0%2.6 $0.38 4/30/2024287,300 shares $103,428.00 +73.9%1.1%2.5 $0.36 4/15/2024165,200 shares $49,758.24 -22.7%0.6%2 $0.30 3/31/2024213,800 shares $80,623.98 -4.2%0.8%2.1 $0.38 3/15/2024223,200 shares $83,253.60 -17.3%0.8%0.3 $0.37 2/29/2024269,900 shares $116,057.00 -21.9%1.0%0.4 $0.43 2/15/2024345,400 shares $146,795.00 +15.1%1.3%0.5 $0.43 1/31/2024300,000 shares $135,030.00 -30.4%1.2%0.1 $0.45 1/15/2024430,700 shares $232,147.30 -44.1%1.6%0.2 $0.54 12/31/2023769,900 shares $508,134.00 +60.8%2.9%0.3 $0.66 12/15/2023478,900 shares $182,987.69 -42.6%1.8%0.2 $0.38 11/30/2023834,000 shares $358,703.40 -44.4%3.2%0.3 $0.43 11/15/20231,500,000 shares $557,700.00 +260.1%5.7%0.6 $0.37 10/31/2023416,500 shares $116,536.70 -8.2%1.6%0.2 $0.28 10/15/2023453,800 shares $137,002.22 +100.6%1.7%1.6 $0.30 9/30/2023226,200 shares $93,420.60 +7.2%0.9%0.9 $0.41 9/15/2023211,000 shares $122,823.10 -32.7%0.8%2.9 $0.58 8/31/2023313,400 shares $203,710.00 -6.8%1.5%4.6 $0.65 8/15/2023336,300 shares $242,472.30 -10.1%1.6%4.8 $0.72 7/31/2023374,200 shares $322,560.40 -12.3%1.9%5.3 $0.86 7/15/2023426,500 shares $298,550.00 +24.9%2.1%4.4 $0.70 6/30/2023341,400 shares $214,057.80 -15.1%1.4%3.5 $0.63 6/15/2023402,300 shares $402,300.00 -12.8%1.6%4.6 $1.00 5/31/2023461,100 shares $407,566.29 -11.0%1.8%5.3 $0.88 5/15/2023517,900 shares $502,363.00 +2.9%2.0%5.8 $0.97 4/30/2023503,500 shares $493,430.00 -0.5%1.9%5.4 $0.98 4/15/2023506,100 shares $541,527.00 +0.2%2.0%4.9 $1.07 3/31/2023505,200 shares $596,136.00 -9.0%2.0%5.3 $1.18 3/15/2023555,200 shares $705,104.00 +12.6%2.2%5.4 $1.27Elon Musk has put himself in their crosshairs (Ad)Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.I share with you in this special investigative documentary. 2/28/2023493,100 shares $739,650.00 -4.4%1.9%2.7 $1.50 2/15/2023515,500 shares $860,885.00 -13.1%2.0%2.8 $1.67 1/31/2023593,300 shares $1.09 million -5.1%1.7%2.8 $1.83 1/15/2023625,100 shares $1.18 million +1.6%1.8%2.4 $1.89 12/30/2022615,500 shares $867,855.00 +65.6%1.8%0.9 $1.41 12/15/2022371,800 shares $565,136.00 -12.3%1.1%0.1 $1.52 11/30/2022423,900 shares $974,970.00 -6.8%1.2%0.1 $2.30 11/15/2022454,700 shares $1.10 million -12.0%1.3%0.1 $2.43 10/31/2022516,900 shares $1.20 million -20.1%1.5%0.1 $2.32 10/15/2022646,600 shares $2.11 million -1.8%1.9%0.1 $3.27 9/30/2022658,400 shares $1.43 million +265.6%1.9%0.1 $2.17 9/15/2022180,100 shares $405,225.00 -23.0%0.5%0.1 $2.25 8/31/2022234,000 shares $458,640.00 -16.1%0.7%0.2 $1.96 8/15/2022278,800 shares $568,752.00 -3.5%0.8%0.2 $2.04 7/31/2022288,900 shares $904,257.00 +110.1%0.9%0.2 $3.13 7/15/2022137,500 shares $247,500.00 No Change0.4%0.4 $1.80 SNTI Short Interest - Frequently Asked Questions What is Senti Biosciences' current short interest? Short interest is the volume of Senti Biosciences shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 65,100 shares of SNTI short. 2.27% of Senti Biosciences' shares are currently sold short. Learn More on Senti Biosciences' current short interest. What is a good short interest ratio for Senti Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNTI shares currently have a short interest ratio of 2.0. Learn More on Senti Biosciences's short interest ratio. What is a good short interest percentage for Senti Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.27% of Senti Biosciences' floating shares are currently sold short. Is Senti Biosciences' short interest increasing or decreasing? Senti Biosciences saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 65,100 shares, an increase of 10.0% from the previous total of 59,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Senti Biosciences' float size? Senti Biosciences currently has issued a total of 4,580,000 shares. Some of Senti Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Senti Biosciences currently has a public float of 2,870,000 shares. How does Senti Biosciences' short interest compare to its competitors? 2.27% of Senti Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Senti Biosciences: Carisma Therapeutics, Inc. (4.00%), Achilles Therapeutics plc (0.41%), Passage Bio, Inc. (3.21%), Elevation Oncology, Inc. (12.42%), CERo Therapeutics Holdings, Inc. (3.91%), DURECT Co. (3.35%), Lantern Pharma Inc. (2.06%), Daré Bioscience, Inc. (0.35%), CalciMedica, Inc. (1.36%), OKYO Pharma Limited (1.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Senti Biosciences stock? Short selling SNTI is an investing strategy that aims to generate trading profit from Senti Biosciences as its price is falling. SNTI shares are trading up $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Senti Biosciences? A short squeeze for Senti Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNTI, which in turn drives the price of the stock up even further. How often is Senti Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNTI, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Carisma Therapeutics Short Interest Achilles Therapeutics Short Interest Passage Bio Short Interest Elevation Oncology Short Interest CERo Therapeutics Short Interest DURECT Short Interest Lantern Pharma Short Interest Daré Bioscience Short Interest CalciMedica Short Interest OKYO Pharma Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNTI) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredThis small cap’s electric marine powertrain broke the world speed recordThe future of marine propulsion has arrived-powered by a $2 billion powerhouse. In collaboration with McLar...The Tomorrow Investor | SponsoredThe next assassination attempt won’t be on TrumpPresident Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you wa...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | SponsoredBreaking News: Are Trump/Musk Planning an AI Takeover? (Shocking)Now that he is Donald Trump’s right-hand man… You owe it to yourself to see Elon Musk’s big AI prediction f...Traders Agency | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senti Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senti Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.